Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zipeng Wu

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 17, 2025
Polymeric micellar paclitaxel, cisplatin, and tislelizumab as first-line therapy for advanced unresectable esophageal squamous cell carcinoma: A phase II study with resistance profiling in poor respondersCaolu Liu, Zipeng Wu, Yingying Dai, et al.
Clinical and Translational Medicine|June 19, 2025
Long-term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinomaLin Lu, Lei Xia, Xinhong Shi, et al.
Frontiers in Oncology|April 12, 2024
Optimal response to tislelizumab plus chemotherapy in metastatic triple-negative breast cancer: a case report and literature reviewYuxin Ma, Xinhong Shi, Kun Zhao, et al.
ACS Applied Materials & Interfaces|March 21, 2019
Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung CancerJiantong Dong, Ryan Y Zhang, Na Sun, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 17, 2025
Polymeric micellar paclitaxel, cisplatin, and tislelizumab as first-line therapy for advanced unresectable esophageal squamous cell carcinoma: A phase II study with resistance profiling in poor respondersCaolu Liu, Zipeng Wu, Yingying Dai, et al.
Clinical and Translational Medicine|June 19, 2025
Long-term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinomaLin Lu, Lei Xia, Xinhong Shi, et al.
Frontiers in Oncology|April 12, 2024
Optimal response to tislelizumab plus chemotherapy in metastatic triple-negative breast cancer: a case report and literature reviewYuxin Ma, Xinhong Shi, Kun Zhao, et al.
ACS Applied Materials & Interfaces|March 21, 2019
Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung CancerJiantong Dong, Ryan Y Zhang, Na Sun, et al.
Pageof 3